One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor
Science Advances · 2025
DOI: 10.1126/sciadv.ado7373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Wei Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Immunity, Immune Evasion, Major Histocompatibility Complex. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer immunotherapies rely on CD8 + cytolytic T lymphocytes (CTLs) in recognition and eradication of tumor cells via antigens presented on major histocompatibility complex class I (MHC-I) molecules. However, we observe MHC-I deficiency in human and murine urologic tumors, posing daunting challenges for successful immunotherapy. We herein report an unprecedented nanosonosensitizer of one-dimensional bamboo-like multisegmented manganese dioxide@manganese–bismuth vanadate (BMMBV) to boost multiple branches of immune responses targeting MHC-I–deficient tumors. BMMBV markedly augments sonodynamic activity contributed by manganese heteroatoms in the lattice of bismuth vanadate with narrowing bandgaps. Under sonoirradiation, BMMBV enhances tumor antigen spreading and emission of adjuvant signals, which potentiate dendritic cell maturation, thereby eliciting high aptitude of CTLs. This therapy substantially up-regulates MHC expression on tumor cells, which are reversely sensitive to CTLs. Alongside, extensive innate immune cells complement the cytolytic activity of CTLs for eliminating mouse urologic tumors. This study offers a reinforced strategy against antigen-loss immune-evasive tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P. R. China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.
- School of Materials Science and Engineering, Shanghai University, Shanghai 200444, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, Zhejiang 325088, P. R. China.
- Shanghai Institute of Materdicine, Shanghai 200051, P. R. China.
ORCID-Profile: Wei Yang, Sichen Di, Zihuan Yang, Jianwei Cao, Hongze Ren, Yujie Xie, Xinyue Dai, Meihua Yu, Yu Chen, Xingang Cui
Zitieren
APA
Yang, W., Di, S., Yang, Z., Cao, J., Fu, Q., Ren, H., Cheng, H., Xie, Y., Jia, W., Dai, X., Yu, M., Chen, Y., & Cui, X. (2025). One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor. Science Advances. https://doi.org/10.1126/sciadv.ado7373
Vancouver
Yang W, Di S, Yang Z, Cao J, Fu Q, Ren H, et al. One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor. Science Advances. 2025. doi:10.1126/sciadv.ado7373
BibTeX
@article{Yang2025,
author = {Yang, Wei and Di, Sichen and Yang, Zihuan and Cao, Jianwei and Fu, Qingqiao and Ren, Hongze and Cheng, Hui and Xie, Yujie and Jia, Wencong and Dai, Xinyue and Yu, Meihua and Chen, Yu and Cui, Xingang},
title = {One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ado7373}
}
EUVIMED